Treatment of Acne Scarring With a Novel Procedure Combination

Clinical Trial Description

The primary objective of this study is to determine whether the use of subcision in conjunction with calcium hydroxylapatite injections will improve the appearance of rolling acne scars better than subcision alone. ;

Study Design

Related Conditions & MeSH terms

See also
Status	Clinical Trial	Phase
Completed	`NCT00641420` - Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin	N/A
Completed	`NCT01644435` - A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring	Phase 1/Phase 2
Completed	`NCT05386732` - Safety and Efficacy of the 4MD Micro Needling Device in the Treatment of Acne Scars
Completed	`NCT02174393` - Microneedling Plus the Universal Peel For Acne Scarring	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00641420 - Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin

N/A

Completed

NCT01644435 - A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring

Phase 1/Phase 2

Completed

NCT05386732 - Safety and Efficacy of the 4MD Micro Needling Device in the Treatment of Acne Scars

Completed

NCT02174393 - Microneedling Plus the Universal Peel For Acne Scarring

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00510055
Study type	Interventional
Source	Northwestern University
Contact
Status	Completed
Phase	N/A
Start date	June 2007
Completion date	July 2009

Treatment of Acne Scarring With a Novel Procedure Combination

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms